Search clinical trials for: Chidamide, Lenalidomide
Total 1213 results
-
M.D. Anderson Cancer CenterSanofiRecruitingMultiple MyelomaUnited States
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Peking Union Medical College HospitalRecruiting
-
Seoul National University HospitalRecruitingRelapsed/Refractory Diffuse Large B Cell LymphomaKorea, Republic of
-
CelgeneCompletedMyelodysplastic SyndromesUnited States, Germany
-
University Hospital, ToulouseCelgene; Intergroupe Francophone du MyelomeCompleted
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedKidney CancerUnited States
-
Winston LaboratoriesCompleted
-
Fudan UniversityUnknownNeoplasms | Immune System Diseases | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Gemcitabine | Cisplatin | Dexamethasone | Rituximab | Cyclophosphamide | Chidamide | Neoplasm by Histology | HDAC InhibitorChina
-
Peking UniversityNot yet recruitingPeripheral T-cell LymphomaChina
-
CelgeneCompletedMultiple MyelomaUkraine, Russian Federation
-
King's College Hospital NHS TrustCompleted
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University Health Network, TorontoCelgene CorporationCompleted
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Winston LaboratoriesTerminatedPostherpetic NeuralgiaUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedFollicular LymphomaFrance
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
Samyang Biopharmaceuticals CorporationChungnam National University HospitalCompleted
-
Lymphoma Study AssociationCompletedLymphoma, Large B-Cell, Diffuse | Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaFrance
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Beijing Friendship HospitalRecruiting
-
German CLL Study GroupCelgeneCompletedChronic Lymphocytic LeukemiaGermany
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
TelikCompletedMyelodysplastic SyndromeUnited States
-
Fudan UniversityNot yet recruiting
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Winston LaboratoriesNot yet recruitingEpisodic Cluster Headache
-
Ruijin HospitalUnknown
-
Henan Cancer HospitalRecruiting
-
Johns Hopkins All Children's HospitalTerminatedCentral Nervous System TumorsUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixThe Cleveland Clinic; National Institute on Aging (NIA)RecruitingCognitive Dysfunction | Neurodegeneration | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, BrainUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalMemorial Sloan Kettering Cancer Center; Mayo Clinic; Dana-Farber Cancer Institute and other collaboratorsCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes | Refractory Anemia | Refractory Anemia With Excess Blasts | Refractory Cytopenia With... and other conditionsUnited States
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Attaya SuvannasankhaCelgeneCompletedLenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple MyelomaMultiple MyelomaUnited States
-
Bionor Immuno ASCelgene CorporationCompleted
-
The First Affiliated Hospital of Xiamen UniversityThe First Affiliated Hospital with Nanjing Medical University; Sun Yat-sen... and other collaboratorsRecruitingFollicular Lymphoma | DLBCL - Diffuse Large B Cell LymphomaChina
-
Institute of Hematology & Blood Diseases HospitalRecruitingMarginal Zone LymphomaChina
-
Memorial Sloan Kettering Cancer CenterColumbia University; Montefiore Medical Center; Weill Medical College of Cornell... and other collaboratorsCompleted
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ChicagoCelgene CorporationCompleted
-
Samsung Medical CenterRecruiting